IRIS
SPALLONE, VINCENZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.924
EU - Europa 3.754
AS - Asia 854
SA - Sud America 114
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 8
Totale 42.710
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 37.784
IT - Italia 1.350
UA - Ucraina 544
DE - Germania 460
CN - Cina 366
IE - Irlanda 348
FR - Francia 308
KR - Corea 247
GB - Regno Unito 162
PL - Polonia 156
SE - Svezia 115
FI - Finlandia 104
MX - Messico 89
ES - Italia 50
AU - Australia 40
IN - India 35
CA - Canada 32
CO - Colombia 28
RU - Federazione Russa 27
JP - Giappone 26
VN - Vietnam 26
CH - Svizzera 22
KG - Kirghizistan 22
PE - Perù 21
NL - Olanda 20
BE - Belgio 18
SG - Singapore 18
CL - Cile 17
HK - Hong Kong 17
TR - Turchia 17
BR - Brasile 15
EC - Ecuador 14
HU - Ungheria 14
EU - Europa 12
IR - Iran 12
RO - Romania 12
DK - Danimarca 11
PH - Filippine 11
TH - Thailandia 11
AR - Argentina 9
BG - Bulgaria 8
ID - Indonesia 8
PK - Pakistan 8
BO - Bolivia 7
CR - Costa Rica 7
GR - Grecia 7
MY - Malesia 7
TW - Taiwan 6
EG - Egitto 5
GT - Guatemala 5
IQ - Iraq 4
DO - Repubblica Dominicana 3
IL - Israele 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AT - Austria 2
BD - Bangladesh 2
CM - Camerun 2
CZ - Repubblica Ceca 2
EE - Estonia 2
MD - Moldavia 2
ME - Montenegro 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PT - Portogallo 2
SA - Arabia Saudita 2
VE - Venezuela 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
HN - Honduras 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 42.710
Salva come PNG Salva come JPEG
Città #
Wilmington 11.061
Woodbridge 10.987
Houston 9.987
Fairfield 804
Chandler 724
Ann Arbor 584
Jacksonville 409
Ashburn 367
Dublin 326
Seattle 276
Cambridge 265
Medford 246
Dearborn 215
Beijing 176
Rome 168
Kraków 153
New York 126
Lawrence 117
Redwood City 104
Menlo Park 80
Milan 69
San Diego 51
Mülheim 38
Mountain View 33
Falls Church 32
Zhengzhou 27
Palo Alto 26
Bologna 25
Florence 23
University Park 23
Bari 21
Dong Ket 20
London 20
Verona 20
Kunming 19
Lima 19
Nanjing 18
Guangzhou 17
Boardman 16
Naples 16
Padova 15
Barcelona 14
Brussels 14
Kansas City 14
Norwalk 14
Palermo 14
Santiago 14
Toronto 14
Budapest 13
Detroit 13
Bogotá 12
Dallas 12
Hefei 12
Hong Kong 12
Napoli 12
Helsinki 11
Nishi 11
Phoenix 11
Modena 10
Trieste 10
Wuhan 10
Mexico 9
Nürnberg 9
Veracruz 9
Zurich 9
Fuzhou 8
Sydney 8
Turin 8
Creede 7
Genova 7
Jinan 7
Messina 7
Parma 7
Redmond 7
Salerno 7
San Mateo 7
Vicenza 7
Indiana 6
La Paz 6
Lahaina 6
Madrid 6
Pisa 6
Quito 6
Seoul 6
Torino 6
Washington 6
Amsterdam 5
Austin 5
Bangkok 5
Baotou 5
Birmingham 5
Campi Bisenzio 5
Cellatica 5
Copertino 5
Cosenza 5
Guayaquil 5
Hangzhou 5
Heroica Matamoros 5
Hyderabad 5
Izmir 5
Totale 38.217
Salva come PNG Salva come JPEG
Nome #
Validation of the Composite Autonomic Symptom Score 31 (COMPASS 31) for the assessment of symptoms of autonomic neuropathy in people with diabetes 957
Diagnosis and treatment of pain in plexopathy, radiculopathy, peripheral neuropathy and phantom limb pain. Evidence and recommendations from the Italian Consensus Conference on Pain on Neurorehabilitation 745
Neuropatia Diabetica 553
Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy 485
Neuropatia Diabetica 482
Obstructive Sleep Apnoea Syndrome and Diabetes. Fortuitous Association or Interaction? 464
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes 453
Raccomandazioni sull’uso dei test cardiovascolari nella diagnosi di neuropatia autonomica diabetica 449
Il trattamento della psoriasi nell’adulto. Linea guida 25. 448
Diagnostic value of different autonomic symptoms assessed by COMPASS 31 for cardiovascular autonomic neuropathy and diabetic polyneuropathy 447
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management 428
Pancreatic polypeptide response to a protein-rich meal in diabetic patients with and without neuropathy 426
Long-term outcomes of diabetic patients with critical limb ischemia followed in a tertiary referral diabetic foot clinic 425
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments 422
Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients 420
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit 420
Influence of glucoregulation with continuous subcutaneous insulin infusion on nerve conduction velocity and beat to beat variation in diabetics 414
Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients. 413
TCF7L2 gene polymorphisms and type 2 diabetes: Association with diabetic retinopathy and cardiovascular autonomic neuropathy 412
Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy 411
Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria 409
Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I-MIBG 408
Does autonomic neuropathy play a role in erythropoietin regulation in non-proteinuric Type 2 diabetic patients? 407
Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. 405
1965-2015, 1991-2015. 50 years of the EASD, 25 years of Neurodiab. Enduring friendship. A legacy for the future 405
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy 403
Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes 402
Regression of microalbuminuria in type II diabetic,hypertensive patients after long-term indapamide treatment 402
Neuropatia e assistenza al diabetico 402
Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes 402
Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy 400
Change in glucose metabolism after long-term treatment with deflazacort and betamethasone 397
Diagnosis of cardiovascular autonomic neuropathy in diabetes 394
The relationship of autonomic neuropathy to other diabetic complications 394
Twenty-four-hour pattern of blood pressure and spectral analysis of heart rate variability in diabetic patients with various degrees of autonomic neuropathy. Comparison to standard cardiovascular tests. 392
Psychological considerations in the assessment and treatment of pain in neurorehabilitation and psychological factors predictive of therapeutic response: Evidence and recommendations from the Italian consensus conference on pain in neurorehabilitation 392
Combination Therapy in Diabetic Neuropathy 391
Intravenous dexamethasone and subsequent ACTH test in comparison with dexamethasone oral test in the diagnosis of Cushing's syndrome: a report of 20 cases 390
IS DN4 AS A SCREENING TOOL FOR NEUROPATHIC PAIN SUITABLE FOR PAINFUL DIABETIC POLYNEUROPATHY? 389
A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy 387
Might genetics play a role in understanding and treating diabetic polyneuropathy? 387
Perspectives in Diabetic Neuropathy: Update on Diagnostic Criteria and Treatment Options 387
Study of conduction velocity in diabetic with autonomic neuropathy. 385
Effects of somatostatin on established induced ketosis 385
Psychopathology and dietary restriction: A comparison between eating disorders and Type 1 diabetes 384
Carbohydrate metabolism in hypertension: influence of treatment 381
Psychological treatments and psychotherapies in the neurorehabilitation of pain: Evidences and recommendations from the italian consensus conference on pain in neurorehabilitation 381
Efficacy and safety of lacosamide in painful diabetic neuropathy 380
Recent advances in exploring the genetic susceptibility to diabetic neuropathy 380
GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6). 379
Benfotiamine: Commentary and update on recent studies 379
Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes 378
Autonomic neuropathy: Clinical and instrumental findings 375
Management of painful diabetic neuropathy: guideline guidance or jungle? 371
Neuropatia diabetica autonomica, pressione arteriosa e funzione renale (Valsalva Lecture) 370
Methods of investigation for cardiac autonomic dysfunction in human research studies 369
Diabetic autonomic neuropathy 365
Prevenzione degli eventi avversi correlati alla presenza di complicanze del diabete (ipotensione ortostatica, danno renale acuto da mezzo di contrasto e ulcere da pressione) 365
High GADA titer increases the risk of insulin requirement in LADA patients: A 7-year follow-up (NIRAD study 7) 365
MicroRNA genetic variations: association with type 2 diabetes 364
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 364
Need for pathogenetically oriented therapy of neuropathy in diabetes mellitus 363
Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function 360
Reply to Circulating erythropoietin in diabetes mellitus. 359
A Novel Association Between Nondipping and Painful Diabetic Polyneuropathy 358
Il corretto iter diagnostico della Neuropatia Diabetica 357
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 357
Prevalence and characteristics of neuropathic pain in painful diabetic polyneuropathy 357
Neuropatia diabetica in Italia 356
Painful and painless diabetic neuropathy: one disease or two? 356
Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction 355
Neuropathy in chronic kidney disease 355
Should we avoid the handgrip test in the assessment of cardiovascular autonomic neuropathy in diabetic patients? Exploratory factor analysis 355
Improvement in peripheral and autonomic neuropathy during 18 months of treatment with subcutaneous continuous insulin infusion in type 1 diabetics 353
Neuropathic pain impact on sleep and circadian rhythm of blood pressure in painful diabetic polyneuropathy 352
Reappraisal of the diagnostic role of orthostatic hypotension in diabetes 348
Autonomic neuropathy and secondary hyperparathyroidism in uraemia 347
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 346
Relationship between hyperfunction of antral G cells (AGCH) and autonomic neuropathy (AN) in diabetic patients 343
Microvascular complications in children and adolescents with type 1 diabetes 339
Painful Diabetic Polyneuropathy: Approach to Diagnosis and Management 337
Time for a Consensus Conference on pain in neurorehabilitation. 337
Costruire l'identità del nutrizionista 334
Le nuove frontiere della nutrizione. 332
Disfunzione autonomica gastro-enterica e genito-urinaria 331
Impaired alpha cell function in conditions with cortisol deficiency 331
Novità in Endocrinologia. Calcificazione vascolare e osteolisi nella neuropatia diabetica - il legame mancante è il RANK-L? 329
Screening e trattamento della neuropatia diabetica 329
Why not to use the handgrip test in the assessment of cardiovascular autonomic neuropathy among patients with diabetes mellitus? 329
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial 328
Validity of DN4 as a screening tool for neuropathic pain of painful diabetic polyneuropathy 327
Twenty-four hours blood pressure and heart rate profiles in diabetics with and without autonomic neuropathy 325
Terapia farmacologica della neuropatia diabetica dolorosa 323
Glycaemic control and gastric emptying 322
Comparative study of periferal and autonomic neuropathy in diabetes 316
Nondipping is a novel associated disorder of painful diabetic polyneuropathy 310
Position Statement sull’appropriatezza nella prescrizione degli esami di laboratorio in diabetologia 309
The nerve axon reflex-vasodilation for the assessment of small nerve fibers' dysfunction in diabetic patients 306
Mancato effetto dell’iperinsulinemia esogena sui valori della pressione arteriosa e sull’attività simpatica nei soggetti con diabete di tipo 1 e neuropatia autonomica 302
Blood Pressure Variability and Autonomic Dysfunction 300
Totale 38.712
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.865
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.865
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.274 0 0 0 0 0 0 0 0 0 0 1.151 1.123
2019/202011.726 956 947 883 1.017 934 1.271 1.026 969 1.018 965 846 894
2020/20217.117 744 871 780 905 816 742 922 681 185 96 278 97
2021/20221.378 48 178 76 95 87 168 60 68 73 93 90 342
2022/20232.062 195 131 103 235 182 410 174 145 197 55 141 94
2023/2024838 100 54 72 78 105 175 49 69 55 75 6 0
Totale 43.155